PedAM
Pediatric Disease Annotations & Medicines
| Disease | asthma |
| Phenotype | C0004030|aspergillosis |
| Sentences | 16 |
| PubMedID- 23750172 | Allergic bronchopulmonary aspergillosis affects patients with asthma and bronchiectasis. |
| PubMedID- 23210682 | Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. |
| PubMedID- 22053309 | Allergic bronchopulmonary aspergillosis, predominantly a disease of the asthmatics, is well established worldwide for nearly six decades with reports from around the globe [3], while aas is comparatively a more recently identified entity that is now known for the last 30 years. |
| PubMedID- 21603163 | Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis. |
| PubMedID- 26187954 | Allergic bronchopulmonary aspergillosis affects patients with asthma and cystic fibrosis, and is important to recognise as permanent lung or airways damage may accrue if untreated. |
| PubMedID- 24748808 | Thus, although ige levels may be helpful in the diagnosis of allergic bronchopulmonary aspergillosis, with features of asthma and eosinophilia, the total ige has little utility in evaluation of most patients with asthma. |
| PubMedID- 23827645 | Background and objective: the prevalence of allergic bronchopulmonary aspergillosis (abpa) in patients with bronchial asthma remains unknown. |
| PubMedID- 25705310 | asthma with allergic bronchopulmonary aspergillosis (abpa), a hypersensitivity disease of the lungs due to an immune response to aspergillus fumigattus (af) antigens, is rarely seen in children, other than complicating cystic fibrosis. |
| PubMedID- 21402950 | Aspergillus fumigatus is commonly associated with allergic bronchopulmonary aspergillosis in patients with severe asthma in which chronic airway neutrophilia predicts a poor outcome. |
| PubMedID- 25125809 | [4] allergic aspergillosis clinically presents with poorly controlled asthma, fleeting pulmonary opacities and bronchiectasis. |
| PubMedID- 25354514 | Allergic bronchopulmonary aspergillosis affects patients with asthma and cystic fibrosis, and is important to recognise as permanent lung or airways damage may accrue if untreated. |
| PubMedID- 22794704 | Total serum ige can be measured and is helpful in determining atopic presentations such as in allergic bronchopulmonary aspergillosis or in patients with persistent asthma who are candidates for monoclonal anti-ige antibody therapy with, omalizumab. |
| PubMedID- 19207831 | Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with acute severe asthma in a respiratory intensive care unit in north india. |
| PubMedID- 25620428 | The diagnostic criteria for allergic bronchopulmonary aspergillosis in children with poorly controlled asthma need to be re-evaluated. |
| PubMedID- 22794691 | Allergic bronchopulmonary aspergillosis (abpa) occurs in patients with asthma or cystic fibrosis resulting in pulmonary infiltrates, tenacious mucus plugs that harbor hyphae of aspergillus fumigatus, elevations of total serum ige concentration and peripheral blood, and sputum eosinophilia. |
| PubMedID- 26265625 | Integrated therapy for invasive pulmonary aspergillosis in a patient with asthma and chronic obstructive pulmonary disease overlap syndrome. |
Page: 1